LP411833-9
MDM2 gene amplification
Active
Description
MDM2 gene amplification studies evaluate the number of copies of the MDM2 gene present in a single cell to aid in the differential diagnosis between well-differentiated liposarcoma and benign lipoma. Amplification is determined based on the MDM2 gene copy number and MDM2 to centromere ratio (CEP12). An MDM2/CEP12 ratio of >= 2 strongly supports a diagnosis of well-differentiated liposarcoma. PMID: 24515760 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- MDM2 gene amplification
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2019-10-03
- Construct for LOINC Short Name
- MDM2 amplification
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP411833-9
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | MDM2 基因扩增 Synonyms: MDM2 原癌基因; |
| it-IT | Italian (Italy) | MDM2, amplificazione gene Synonyms: Amplificazione del gene MDM2 |
| es-ES | Spanish (Spain) | Amplificación del gen MDM2 |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright